Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

NeoGenomics, Inc. - Common Stock (NQ: NEO )

10.40 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EST, Feb 26, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about NeoGenomics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
12 13 Next >
NeoGenomics to Share Nine Abstracts at the American Association of Cancer Research (AACR) Annual Meeting 2023
Via ACCESSWIRE
Looking Into NeoGenomics's Return On Capital Employed
Via Benzinga
NeoGenomics to Host Investor Day on April 4, 2023
Via ACCESSWIRE
Massive Bio and NeoGenomics Announce Collaboration to Accelerate Oncology Drug Discovery and Improve Patient Care
From Massive Bio, Inc.
Via Business Wire
Analyst Ratings for NeoGenomics
Via Benzinga
Cowen & Co. Maintains Outperform Rating for NeoGenomics: Here's What You Need To Know
Via Benzinga
Why Shares of NeoGenomics Jumped Today
The company released promising earnings results. 
Via The Motley Fool
Why NeoGenomics Shares Are Trading Higher Today
Via Benzinga
3 Supercharged Stocks Near 52-Week Highs That Could Keep Climbing
The high-flyers have soared to new heights and further gains could be up ahead. 
Via The Motley Fool
NeoGenomics Announces Commercial Availability of the RaDaR(R) Molecular Residual Disease Test
Via ACCESSWIRE
NeoGenomics Expands NGS Portfolio with Launch of Neo Comprehensive(TM) - Solid Tumor CGP and Neo Comprehensive(TM) - Myeloid Disorders CGP
Via ACCESSWIRE
NeoGenomics to Present at the 44th Annual Raymond James Institutional Investors Conference
Via ACCESSWIRE
Benzinga's Top Ratings Upgrades, Downgrades For February 24, 2023
Via Benzinga
Crude Oil Rises 1.5%; NeoGenomics Shares Spike Higher
U.S. stocks traded slightly higher toward the end of trading, with the Nasdaq Composite gaining around 50 points on Thursday. The Dow traded down 0.03% to 33,036.50 while the NASDAQ rose 0.46% to... 
Via Benzinga
Why Domino's Pizza Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Gainers 
Via Benzinga
NeoGenomics Reports Fourth Quarter and Full Year 2022 Results
Via ACCESSWIRE
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
US Stocks Turn Lower; Dow Drops 150 Points
U.S. stocks turned lower midway through trading, with the Dow Jones dropping around 150 points on Thursday. The Dow traded down 0.47% to 32,889.30 while the NASDAQ fell 0.47% to 11,452.63. The S&P 500... 
Via Benzinga
Comfort Systems, Gannett, CommScope And Other Big Stocks Moving Higher On Thursday
U.S. stocks traded slightly lower, with the Dow Jones dropping around 30 points on Thursday. Here are some big stocks recording gains in today’s session. 
Via Benzinga
Bronstein, Gewirtz & Grossman, LLC Notifies Shareholders of NeoGenomics Laboratories, Inc. (NEO) Investigation
From Bronstein, Gewirtz & Grossman, LLC
Via Business Wire
Earnings Scheduled For February 23, 2023
Companies Reporting Before The Bell • ChipMOS TECHNOLOGIES (NASDAQ:IMOS) is likely to report earnings for its fourth quarter. 
Via Benzinga
NeoGenomics, Inc. (NASDAQ:NEO) Investor Notice: Deadline in Lawsuit on February 6, 2023
San Diego, CA -- (SBWIRE) -- 02/06/2023 -- The Shareholders Foundation announced that a deadline is coming up on February 6, 2023 in the lawsuit filed for certain investors of NeoGenomics, Inc.... 
Via SBWire
NEO FINAL DEADLINE TODAY: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages NeoGenomics, Inc. Investors to Secure Counsel Before Important February 6 Deadline in Securities Class Action - NEO
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Fraud Lawsuit
Exposures Financial Legal
Final Deadline Alert: Bronstein, Gewirtz & Grossman, LLC Notifies NeoGenomics, Inc. (NEO) Investors of Class Action and to Actively Participate
From Bronstein, Gewirtz & Grossman, LLC
Via Business Wire
NeoGenomics Schedules its Fourth Quarter and Full Year 2022 Earnings Release for February 23, 2023
Via ACCESSWIRE
RaDaR(R) Assay Demonstrates Clinical Potential for Helping Oncologists Determine Whether or Not Muscle-Invasive Bladder Cancer Patients Undergo Radical Surgery
Via ACCESSWIRE
NEO DEADLINE: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages NeoGenomics, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important February 6 Deadline in Securities Class Action - NEO
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Lawsuit
Exposures Financial Legal
NEOGENOMICS 72 HOUR DEADLINE ALERT: Former Louisiana Attorney General and Kahn Swick & Foti, LLC Remind Investors With Losses in Excess Of $100,000 of Deadline in Class Action Lawsuit Against NeoGenomics, Inc. - NEO
From Kahn Swick & Foti, LLC
Via Business Wire
NEOGENOMICS DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against NeoGenomics, Inc. and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire, P.C.
Via Business Wire
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against F45 Training, Silvergate, NeoGenomics, and Iris and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
< Previous 1 2 3 4 5 6 7 8 9
...
12 13 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.